bpc-157 human evidence safety review vs. TB-500: What Patients Should Know bpc-157 human studies clinical trials

Peptide half-life refers to the amount of time required for a peptide compound to lose half of its biological activity or concentration due to degradation

This notice is required under the Federal Food, Drug, and Cosmetic Act.

Sheep, Goats, and Cattle Sheep and other large livestock such as goats and cattle need B12 for normal growth

Once chemists understood the three clearance routes, extending half-life became an engineering problem: block the enzymes, defeat the kidney filter, or anchor the peptide to something large and slow

Two separate human clinical trials (ulcerative colitis and multiple sclerosis) proceeded without significant adverse event reporting

Available Pack Sizes